Streetbeat News

Stock Prices

FRO

Frontline (NYSE:FRO) is expected to release its quarterly earnings report on Thursday, 2023-11-30, with an estimated EPS of $0.45. Investors are looking for an earnings beat and positive guidance for future growth. Historically, FRO's stock price has reacted to past earnings performances, with a mix of positive and negative post-earnings price changes. Shares are currently trading at $21.63, up 54.49% over the last 52 weeks, indicating a bullish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 2:01 pm

EXPR

Express (NYSE:EXPR) is scheduled to release its quarterly earnings report on Thursday, 2023-11-30. Analysts predict an EPS of $-7.18. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, Express has had mixed results with earnings beats and stock price reactions. Shares are currently trading at $9.51, down 66.28% over the last 52 weeks, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 2:01 pm

OTEX

BMO Capital analyst Thanos Moschopoulos has maintained an Outperform rating on Open Text (NASDAQ:OTEX) and increased the price target from $45 to $48.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 2:01 pm

ULTA

Ulta Beauty (NASDAQ:ULTA) is expected to release its quarterly earnings report on Thursday, 2023-11-30, with an estimated EPS of $4.96. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, Ulta's stock price has shown varied reactions to past earnings performances, with a mix of slight increases and decreases following earnings releases. The stock is currently trading at $417.96, down 11.33% over the last 52 weeks, indicating a bearish sentiment among long-term shareholders ahead of the earnings report.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 2:01 pm

ARGX

Analysts have provided ratings for argenx (NASDAQ:ARGX) with 6 bullish, 1 somewhat bullish, and no bearish ratings in the last quarter. The average price target is $585.0, representing an upside from the current price of $441.11. This target has decreased by 2.86% from the previous target of $602.25. Analyst ratings are opinions on stock performance and are updated quarterly.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 2:00 pm

JAZZ

Over the past 3 months, 4 Wall Street analysts have provided ratings for Jazz Pharmaceuticals (NASDAQ:JAZZ), with 2 bullish, 1 somewhat bullish, and 1 indifferent. The average price target is $194.0, representing an upside from the current price of $114.38, but this is a 2.35% decrease from the previous target of $198.67.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 2:00 pm

TOL

Over the past 3 months, 5 Wall Street analysts have published their ratings on Toll Brothers (NYSE:TOL), with an average 12-month price target of $83.8, a high of $93.00, and a low of $74.00. The current average price target represents a 4.1% increase from the previous target of $80.50. The distribution of ratings includes 1 bullish, 2 somewhat bullish, 1 indifferent, and 1 somewhat bearish, with no bearish ratings. Analysts derive their ratings from various sources, including company calls, financial statements, and insider information.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 2:00 pm

KR

Kroger (NYSE:KR) is expected to release its quarterly earnings report on Thursday, 2023-11-30, with analysts predicting an EPS of $0.90. Investors are looking for an earnings beat and positive guidance for future growth. Historically, Kroger's stock price has shown varied reactions to past earnings reports, with a slight drop after the last quarter despite beating EPS estimates. Over the past year, Kroger's shares have declined by 9.09%, indicating a bearish sentiment among long-term shareholders ahead of the earnings release.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 2:00 pm

PRAX

Trading in shares of Praxis Precision Medicines has resumed.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 2:00 pm

LVS

Las Vegas Sands Corp. (LVS) shares have dropped following the announcement of a common stock offering pricing by its principal stockholder.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 1:49 pm